| abstract |
An isolated human natural IgM antibody immunoreactive with an epitope present on HIV-1 Tat protein is provided. Additionally, a method for the prognosis or diagnosis of AIDS in an individual infected with HIV including the steps of: obtaining a body fluid from the individual, detecting or measuring natural human IgM antibodies in the body fluid of the individual and determining a DELTA 20- DELTA 2 value, and comparing the DELTA 20- DELTA 2 value obtained from the individual with a DELTA 20- DELTA 2 value obtained from clinically normal, non-HIV infected humans, wherein the individual has AIDS or will progress to AIDS within about two years if the individual's DELTA 20- DELTA 2 value is significantly decreased relative to the DELTA 20- DELTA 2 value obtained from the clinically normal humans, is provided. |